PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.26%
Revenue growth under 50% of MRVL's 29.27%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
5.32%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
5.90%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
6.24%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
4.09%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
4.20%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
3.81%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.33%
Share reduction while MRVL is at 18.41%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.43%
Reduced diluted shares while MRVL is at 18.42%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.04%
Dividend growth under 50% of MRVL's 2.72%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-17.54%
Negative OCF growth while MRVL is at 1718.03%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-31.16%
Negative FCF growth while MRVL is at 583.44%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
93.65%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
52.48%
5Y revenue/share CAGR above 1.5x MRVL's 6.94%. David Dodd would look for consistent product or market expansions fueling outperformance.
44.72%
3Y revenue/share CAGR above 1.5x MRVL's 8.77%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
224.56%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
108.31%
5Y OCF/share CAGR at 75-90% of MRVL's 133.28%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
0.26%
3Y OCF/share CAGR under 50% of MRVL's 141.20%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
536.51%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
134.40%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
78.80%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
56.50%
Below 50% of MRVL's 117.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.19%
Below 50% of MRVL's 120.69%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
69.13%
3Y equity/share CAGR above 1.5x MRVL's 29.35%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
573.58%
Dividend/share CAGR of 573.58% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.97%
5Y dividend/share CAGR above 1.5x MRVL's 0.14%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
49.53%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
22.01%
AR growth well above MRVL's 13.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.75%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.86%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-6.43%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
5.88%
R&D dropping or stable vs. MRVL's 28.29%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
No Data
No Data available this quarter, please select a different quarter.